美国国立卫生总署研究员、美中交流中心主任金福生日前到武汉市民企武汉中环集团实业有限公司通报 ,该公司生产的银杏口服液通过美国食品与药品管理局（ＦＤＡ）审查 ,可以在美国销售 ,获准在美注册公司。这是湖北省第一个通过ＦＤＡ审查的产品。武汉银杏口服液获准在美注册并 Jin Fu, a researcher of the US National Health Agency and the director of the China-China Exchange Center, informed Wuhan Wuhan Central Industrial Group Co., Ltd., a Wuhan-based public company, that the company’s Ginkgo oral liquids were vetted by the US Food and Drug Administration (FDA) and could be sold in the United States. , approved to register in the United States. This is the first product in Hubei Province that has passed the FDA review. Wuhan Ginkgo Oral Liquid is approved to be registered in the United States